 Home > Medical News > Medical Research Articles > CStone Announces Presentation of Multispecific Antibody Candidate Therapy CS2006/NM21-1480 Study Data at the 2022 American Association for Cancer Research (AACR) Annual Meeting

CStone Announces Presentation of Multispecific Antibody Candidate Therapy CS2006/NM21-1480 Study Data at the 2022 American Association for Cancer Research (AACR) Annual Meeting

 Last Update: 2022-05-22
 Source: Internet
 Author: User

Tags

ark all dyes

high density polyethylene

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Research Field: Therapeutic Antibodies
Date: April 12, 2022, 9:00am-12:30pm ET
Report form: electronic poster
Title: Dose Selection Study and Combination Administration Strategy of PD-L1/4-1BB/HSA Trispecific Clinical Candidate NM21-1480 Based on MATCH3 Form
Speaker: Dr.

Compared with other PD-L1/4-1BB bispecific candidate antibodies, CS2006/NM21-1480's unique monovalent structure design and ultra-high affinity for PD-L1 will enable dual effects of PD-L1 and 4-1BB in tumor areas maximizing the potential to deliver broader and longer-lasting therapeutic remission to patients while avoiding systemic toxicity

Dr.

CS2006/NM21-1480 is designed and developed by CStone's partner Numab Therapeutics (Numab for short) based on its unique λcap™ technology and MATCH™ platform.

About CStone
CStone Pharmaceuticals (SEHK: 2616) is a biopharmaceutical company focused on the research, development and commercialization of innovative immuno-oncology and precision medicines to meet the high medical needs of cancer patients in China and around the world

To learn more about CStone, please visit:.

Forward-Looking Statements
Forward-looking statements made herein relate only to events or information as of the date on which they are made

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Best price Pure 99% Mecobalamin powder CAS 13422-55-4 Vitamin B12 Methylcobalamin

CAS No.: 13422-55-4

Pharmacy Grade

$2.8-3.2/G FOB

Most professional factory supply good price with best service Ethyl 3-amino-4-(2-phthalimidoethoxy)crotonate

CAS No.: 265136-65-0

Pharmacy Grade

$1.1-1.2/MT FOB

GMP Pharmacy Grade Tirzepatide 10 mg 10 vial pack from China factory Trizep in stock Lyophilized powder

CAS No.: 2023788-19-2

Pharmacy Grade

$50.00/UNIT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.